SUBSEQUENT ANDROGEN DEPRIVATION THERAPY AFTER INITIAL TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: PROSPECTIVE DATA FROM A PHASE III TRIAL

被引：0
|
作者：
Nabid, Abdenour [1 ]
Carrier, Nathalie [1 ]
Vigneault, Eric [2 ]
Thu Van Nguyen [3 ]
Vavassis, Peter [3 ]
Brassard, Marc-Andre [1 ]
Bahoric, Boris [3 ]
Archambault, Robert [4 ,5 ]
Vincent, Francois [3 ]
Bettahar, Redouane [2 ]
Wilke, Derek [6 ]
Souhami, Luis [3 ]
Nabid, Abdenour [1 ]
机构：
[1] Univ Sherbrooke, Sherbrooke, PQ, Canada
[2] Univ Laval, Quebec City, PQ, Canada
[3] Univ Montreal, Montreal, PQ, Canada
[4] Univ Quebec Outaouais, Gatineau, PQ, Canada
[5] McGill Univ, Gatineau, PQ, Canada
[6] Dalhousie Univ, Halifax, NS, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
24
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 50 条
  • [31] Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
    Boeve, Liselotte M. S.
    Hulshof, Maarten C. C. M.
    Vis, Andre N.
    Zwinderman, Aeilko H.
    Twisk, Jos W. R.
    Witjes, Wim P. J.
    Delaere, Karl P. J.
    van Moorselaar, R. Jeroen A.
    Verhagen, Paul C. M. S.
    van Andel, George
    EUROPEAN UROLOGY, 2019, 75 (03) : 410 - 418
  • [32] Androgen deprivation therapy for prostate cancer and osteoporotic risk
    Cortet, B.
    Lartigau, E.
    Caty, A.
    Moulinier, F.
    Staerman, F.
    Villamizar-Vesga, J.
    Villers, A.
    PROGRES EN UROLOGIE, 2012, 22 : S31 - S38
  • [33] Androgen deprivation therapy in high risk prostate cancer
    Van Dams, Ritchell
    Kishan, Amar U.
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2216 - 2217
  • [34] Androgen deprivation therapy for prostate cancer and risk of dementia
    Robinson, David
    Garmo, Hans
    Van Hemelrijck, Mieke
    Damber, Jan-Erik
    Bratt, Ola
    Holmberg, Lars
    Wahlund, Lars-Olof
    Stattin, Par
    Adolfsson, Jan
    BJU INTERNATIONAL, 2019, 124 (01) : 87 - 92
  • [35] Androgen deprivation therapy and cardiovascular risk in prostate cancer
    DE Nunzio, Cosimo
    Fiori, Cristian
    Fusco, Ferdinando
    Gregori, Andrea
    Pagliarulo, Vincenzo
    Alongi, Filippo
    MINERVA UROLOGY AND NEPHROLOGY, 2022, 74 (05): : 508 - 517
  • [36] Short-Term Androgen Deprivation Therapy and High -Dose Radiotherapy in Intermediate- and High -Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial
    Demogeot, N.
    Sargos, P.
    Sahki, N.
    Guerif, S.
    De Crevoisier, R.
    Calais, G.
    Hannoun-Levi, J. M.
    Bouche, G.
    Hennequin, C.
    Cretin, J.
    Belkacemi, Y.
    Khalifa, J.
    Azria, D.
    Bauer, N.
    Pommier, P.
    Pommier, P.
    Simon, J. M.
    Leger, C.
    Beckendorf, V.
    Dubray, B. M.
    Supiot, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S4 - S5
  • [37] Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective
    Teoh, Jeremy Yuen Chun
    Ng, Chi-Fai
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (09) : 1429 - 1435
  • [38] Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective
    Jeremy Yuen Chun Teoh
    Chi-Fai Ng
    International Urology and Nephrology, 2016, 48 : 1429 - 1435
  • [39] AVOIDING ANDROGEN DEPRIVATION THERAPY IN MEN WITH HIGH RISK PROSTATE CANCER: THE ROLE OF RADICAL PROSTATECTOMY AS INITIAL TREATMENT
    Miocinovic, Ranko
    Berglund, Ryan K.
    Stephenson, Andrew J.
    Jones, J. Stephen
    Fergany, Amr F.
    Kaouk, Jihad
    Klein, Eric A.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E354 - E354
  • [40] Risk of fracture after androgen deprivation for prostate cancer
    Shahinian, VB
    Kuo, Y
    Freeman, JL
    Goodwin, JS
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (02): : 154 - 164
12345